The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Staphylococcus aureus Bacteremia: Recurrence and the Impact of Antibiotic Treatment in a Prospective Multicenter Study
Abstract
Staphylococcus aureus bacteremia is associated with substantial morbidity. Recurrence is common, but incidence and risk factors for recurrence are uncertain. The emergence of methicillin resistance and the ease of administering vancomycin, especially in patients who have renal insufficiency, have led to reliance on this drug with the assumption that it is as effective as beta-lactam antibiotics, an assumption that remains open to debate. We initiated a multicenter, prospective observational study in 6 university hospitals and enrolled 505 consecutive patients with S. aureus bacteremia. All patients were monitored for 6 months and patients with endocarditis were followed for 3 years. Recurrence was defined as return of S. aureus bacteremia after documentation of negative blood cultures and/or clinical improvement after completing a course of antistaphylococcal antibiotic therapy. All blood isolates taken from patients with recurrent bacteremia underwent pulsed-field gel electrophoresis testing. Recurrence was subclassified as reinfection (different pulsed-field gel electrophoresis patterns) or relapse (same pulsed-field gel electrophoresis pattern).Forty-two patients experienced 56 episodes of recurrence (79% were relapses and 21% were reinfection). Relapse occurred earlier than reinfection (median, 36 versus 99 d, p < 0.06). Risk factors for relapse of S. aureus bacteremia included valvular heart disease, cirrhosis of the liver, and deep-seated infection (including endocarditis). Nafcillin was superior to vancomycin in preventing bacteriologic failure (persistent bacteremia or relapse) for methicillin-susceptible S. aureus (MSSA) bacteremia. Failure to remove infected intravascular devices/catheters and vancomycin therapy were common factors in patients experiencing multiple (greater than 2) relapses. However, by multivariate analysis, only endocarditis and therapy with vancomycin (versus nafcillin) were significantly associated with relapse. Recurrences occurred in 9.4% of S. aureus bacteremias following antistaphylococcal therapy, and most were relapses. Duration of antistaphylococcal therapy was not associated with relapse, but type of antibiotic therapy was. Nafcillin was superior to vancomycin in efficacy in patients with MSSA bacteremia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., & Swaminathan, B. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.9.2233-2239.1995 · Cited by 8,204
CDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
The APACHE III Prognostic System
Knaus, W. A., Wagner, D. P., Draper, E. A., Zimmerman, J. E., Bergner, M., Bastos, P. G., Sirio, C. A., Murphy, D. J., Lotring, T., Damiano, A., et al. (1991) · Chest · doi:10.1378/chest.100.6.1619 · Cited by 3,439
The APACHE III Prognostic System
Teres, D., & Lemeshow, S. (1992) · Chest · doi:10.1378/chest.102.6.1919b · Cited by 2,880
Durack, D. T., Lukes, A. S., Bright, D. K., & Service, D. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90143-0 · Cited by 2,572
Rimola, A., Soto, R., Bory, F., Arroyo, V., Piera, C., & Rodes, J. (1984) · Hepatology · doi:10.1002/hep.1840040109 · Cited by 460
Fowler, V. G., Sanders, L. L., Sexton, D. J., Kong, L., Marr, K. A., Gopal, A. K., Gottlieb, G., McClelland, R. S., & Corey, G. R. (1998) · Clinical Infectious Diseases · doi:10.1086/514686 · Cited by 441
Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users
Small, P. M., & Chambers, H. F. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1227 · Cited by 399
KORZENIOWSKI, O., & SANDE, M. A. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-4-496 · Cited by 355
Chang, F.-Y., MacDonald, B. B., Peacock, J. E., Musher, D. M., Triplett, P., Mylotte, J. M., O’Donnell, A., Wagener, M. M., & Yu, V. L. (2003) · Medicine · doi:10.1097/01.md.0000091185.93122.40 · Cited by 349
Self-citationMarkowitz, N., Quinn, E. L., & Saravolatz, L. D. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-5-390 · Cited by 343
Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary
Chow, J. W., & Yu, V. L. (1999) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(98)00060-0 · Cited by 320
Self-citationRaad, I. I., & Sabbagh, M. F. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.1.75 · Cited by 224
Chambers, H. F., Miller, R. T., & Newman, M. D. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-8-619 · Cited by 214
Goering, R. V., & Winters, M. A. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.3.577-580.1992 · Cited by 192
Hill, P. C., Birch, M., Chambers, S., Drinkovic, D., Ellis-Pegler, R. B., Everts, R., Murdoch, D., Pottumarthy, S., Roberts, S. A., Swager, C., et al. (2001) · Internal Medicine Journal · doi:10.1046/j.1445-5994.2001.00029.x · Cited by 185
Malanoski, G. J., Samore, M. H., Pefanis, A., & Karchmer, A. W. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.11.1161 · Cited by 161
RecurrentStaphylococcus aureusBacteremia: Pulsed‐Field Gel Electrophoresis Findings in 29 Patients
Fowler, V. G., Kong, L., Corey, G. R., Gottlieb, G. S., McClelland, R. S., Sexton, D. J., Gesty‐Palmer, D., & Harrell, L. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/314712 · Cited by 154
Reticuloendothelial Function in Patients with Alcoholic Liver Cirrhosis
Lahnborg, G., Friman, L., & BERGHEM, L. E. R. (1981) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528109182002 · Cited by 92
Short-Course Therapy for Catheter-Associated Staphylococcus aureus Bacteremia
Ehni, W. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.3.533 · Cited by 76
Chang, F. Y., Singh, N., Gayowski, T., Wagener, M. M., & Marino, I. R. (1998) · Infection Control and Hospital Epidemiology · doi:10.2307/30141373 · Cited by 72
Self-citationRecurrent Staphylococcus aureus bacteremia
Hartstein, A. I., Mulligan, M. E., Morthland, V. H., & Kwok, R. Y. Y. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.3.670-674.1992 · Cited by 66
Rahal, J. J., Chan, Y., & Johnson, G. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90180-4 · Cited by 52
Home Intravenous Antibiotic Therapy Using a Programmable Infusion Pump
Williams, D. N. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390050115023 · Cited by 36
Tolerant Staphylococcus aureus Causing Vertebral Osteomyelitis
Musher, D. M., & Fletcher, T. (1982) · Archives of Internal Medicine · doi:10.1001/archinte.1982.00340160212035 · Cited by 19
Self-citation
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Fowler, V. G., Boucher, H. W., Corey, G. R., Abrutyn, E., Karchmer, A. W., Rupp, M. E., Levine, D. P., Chambers, H. F., Tally, F. P., Vigliani, G. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053783 · Cited by 1,459
Berbari, E. F., Kanj, S. S., Kowalski, T. J., Darouiche, R. O., Widmer, A. F., Schmitt, S. K., Hendershot, E. F., Holtom, P. D., Huddleston, P. M., Petermann, G. W., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ482 · Cited by 1,142
Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-09 · Cited by 962
Metadata
- Authors
- Chang, F.-Y., Peacock, J. E., Musher, D. M., Triplett, P., MacDonald, B. B., Mylotte, J. M., O’Donnell, A., Wagener, M. M., & Yu, V. L.
- Venue
- Medicine
- Published
- 2003-09
- Volume
- 82
- Issue
- 5
- Pages
- 333-339
- ISSN
- 0025-7974 (ISSN-L)
- OpenAlex
- W2082441919
- Cited by
- 530
- References
- 25
- FWCI
- 11.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.